| Revenue | 32.04B |
| Cost of products sold | 30.45B |
| Gross margin | 1.59B |
| Distribution, selling, general and administrative expenses | 920M |
| Restructuring and employee severance | 9M |
| Acquisition-related costs | |
| Impairments and loss on sale of assets | |
| Litigation (recoveries)/charges, net | 1M |
| Operating earnings | 535M |
| Other (income)/expense, net | -3M |
| Interest expense, net | 44M |
| Loss on extinguishment of debt | |
| Gain on sale of investment in CareFusion | |
| Earnings before income taxes and discontinued operations | 494M |
| Provision for income taxes | 184M |
| Earnings from continuing operations | |
| Earnings/(loss) from discontinued operations, net of tax | |
| Net earnings | 309M |
| Continuing operations | 0.97 |
| Discontinued operations | 0.96 |
| Net basic earnings per Common Share | |
| Continuing operations | |
| Discontinued operations | |
| Net diluted earnings per Common Share | |
| Basic | 320M |
| Diluted | 322M |